Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Treatment of Acute Exacerbation of Chronic Bronchitis (AECB) and Community-acquired Pneumonia (CAP) in Adults
Latest Information Update: 07 Jan 2020
At a glance
- Drugs Cefdinir/clavulanic acid (Primary) ; Cefdinir
- Indications Acute exacerbations of chronic bronchitis; Community-acquired pneumonia
- Focus Therapeutic Use
- 07 Jan 2020 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified January 2018).
- 23 Jan 2018 New trial record